| Literature DB >> 33204690 |
Guo-Hua Li1, Li-Ming Ding1, Lei Sun1, Fu Wang1.
Abstract
OBJECTIVE: This paper included a retrospective review of the effect of tranexamic acid (TXA) combined with pressure bandaging on hemostasis of patients who received a unilateral total knee arthroplasty (TKA) from 2017 to 2019.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33204690 PMCID: PMC7655242 DOI: 10.1155/2020/2739560
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
General information and hemoglobin values of the two groups ().
| Control | Observation |
| |
|---|---|---|---|
| Female | 79 | 59 | 0.876 |
| Male | 33 | 26 | |
| Age | 66.70 ± 7.63 | 66.33 ± 8.38 | 0.749 |
| Hemoglobin(Hb, g/L) | |||
| Preoperation | 129.71 ± 13.80 | 130.50 ± 13.37 | 0.972 |
| 1st day | 122.19 ± 13.33 | 122.26 ± 13.18 | 0.946 |
| 3rd day | 110.85 ± 13.65 | 113.56 ± 13.42 | 0.168 |
| 6th day | 112.19 ± 12.18 | 114.23 ± 13.49 | 0.271 |
Comparison of C-reactive protein and D-dimer levels between the two groups ().
| Time | C-reactive protein (CRP, mg/L) | D-dimer (mg/L) | ||||
|---|---|---|---|---|---|---|
| Control | Observation |
| Control | Observation |
| |
| Preoperation | 5.94 ± 12.75 | 3.81 ± 5.67 | 0.154 | 0.61 ± 1.12 | 0.39 ± 0.43 | 0.087 |
| 1st day | 35.67 ± 23.11 | 40.72 ± 28.52 | 0.175 | 4.79 ± 4.64 | 2.90 ± 2.51 | 0.001 |
| 3rd day | 71.02 ± 45.38 | 90.87 ± 57.33 | 0.008 | 1.85 ± 1.48 | 1.42 ± 1.10 | 0.027 |
| 6th day | 32.02 ± 33.57 | 47.27 ± 47.83 | 0.010 | 2.97 ± 2.06 | 2.62 ± 1.57 | 0.190 |
Comparison of ESR and fibrinogen levels between the two groups ().
| Time | Erythrocyte sedimentation rate (ESR, mm/h) | Fibrinogen (g/L) | ||||
|---|---|---|---|---|---|---|
| Control | Observation |
| Control | Observation |
| |
| Preoperation | 25.21 ± 19.09 | 24.04 ± 19.92 | 0.703 | 2.89 ± 0.66 | 2.72 ± 0.58 | 0.070 |
| 1st day | 37.07 ± 23.95 | 43.22 ± 24.30 | 0.084 | 3.15 ± 1.33 | 2.97 ± 0.68 | 0.257 |
| 3rd day | 63.17 ± 26.62 | 72.26 ± 26.25 | 0.021 | 4.57 ± 1.00 | 4.86 ± 1.19 | 0.080 |
| 6th day | 62.96 ± 27.55 | 75.84 ± 30.40 | 0.003 | 4.50 ± 1.30 | 4.65 ± 1.06 | 0.387 |
Comparison of prothrombin time and international normalized ratio between the two groups ().
| Time | Prothrombin time (PT, s) | International normalized ratio (INR) | ||||
|---|---|---|---|---|---|---|
| Control | Observation |
| Control | Observation |
| |
| Preoperation | 11.62 ± 1.35 | 11.87 ± 0.85 | 0.142 | 1.00 ± 0.06 | 1.00 ± 0.07 | 0.744 |
| 1st day | 12.18 ± 1.00 | 12.56 ± 1.01 | 0.011 | 1.27 ± 2.38 | 1.06 ± 0.08 | 0.414 |
| 3rd day | 11.85 ± 0.91 | 12.19 ± 0.90 | 0.010 | 1.01 ± 0.07 | 1.03 ± 0.07 | 0.153 |
| 6th day | 11.97 ± 0.88 | 12.35 ± 0.90 | 0.004 | 1.03 ± 0.07 | 1.05 ± 0.07 | 0.081 |
Comparison of activated partial thromboplastin time and thrombin time between the two groups ().
| Time | Activated partial thromboplastin time (APTT, s) | Thrombin time (TT, s) | ||||
|---|---|---|---|---|---|---|
| Control | Observation |
| Control | Observation |
| |
| Preoperation | 27.09 ± 3.94 | 28.85 ± 3.27 | 0.078 | 17.30 ± 1.63 | 17.80 ± 2.17 | 0.068 |
| 1st day | 27.62 ± 3.42 | 28.27 ± 4.39 | 0.255 | 16.73 ± 1.03 | 16.96 ± 1.79 | 0.260 |
| 3rd day | 28.67 ± 3.64 | 30.59 ± 4.07 | 0.001 | 15.42 ± 1.03 | 15.26 ± 1.89 | 0.450 |
| 6th day | 27.85 ± 4.78 | 30.31 ± 4.92 | 0.001 | 15.59 ± 1.15 | 15.39 ± 2.42 | 0.456 |